FDA approves new nail fungus treatment

FDA approves new nail fungus treatment

(HealthDay)—A new topical nail fungus treatment, Jublia, has been approved by the U.S. Food and Drug Administration.

Jublia (efinaconazole) is made by the Canadian company Valeant Pharmaceuticals International Inc., the Associated Press reported Wednesday.

Jublia comes in liquid form and is applied directly to the nail. According to Valeant, FDA approval was based on two studies involving more than 1,600 people with onychomycosis. The findings were published last year in the Journal of the American Academy of Dermatology. Cure rates were about 18 percent for the patients involved in one study, and about 15 percent for those involved in the other.

In a statement, Valeant said it plans to begin marketing Jublia late in 2014.

More information: Health Highlights: June 11, 2014

add to favorites email to friend print save as pdf

Related Stories

Topical treatment effective for toenail fungal infection

Apr 12, 2013

(HealthDay)—Once daily topical efinaconazole is effective in treating fungal infections of the toenail, according to a study published in the April issue of the Journal of the American Academy of Dermatology.

Recommended for you

FDA OKs Cubist antibiotic for serious infections

13 hours ago

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

carllvsports
not rated yet Aug 09, 2014
Very interesting! I hope this approach can be rolled out into market as soon as possible, and then I'll give it a shot. I have tried tons of ways to deal with this infection, but none of them seemed really effective for me. Vinegar, tea oil, oral medications can only ease the symptoms, but was never able to kill the bacteria. I'm considering taking a laser treatment, but I'm not sure about the real effect. I got some information from here: http://lasernail therapy.com. Is there anyone who had this kind of treatment before? Thanks for advice.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.